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Confocal laser endomicroscopy (CLE) is one of several novel methods that provide real-time, high-resolution imaging at a
micronscale via endoscopes. CLE and related technologies are often termed “virtual biopsy” as they simulate the images seen
in traditional histology. Recently, the use of CLE was reported in the study of colonic mucosa in patients with inﬂammatory bowel
diseases and in particular in patients aﬀected by ulcerative colitis. CLE has the potential to have an important role in management
of IBD patients as it can be used to assess the grading of colitis and in detection of microscopic colitis in endoscopically silent
segments. Moreover, CLE can be used in surveillance programs especially in high-risk patients. This report aims to evaluate the
current data on the application of confocal endomicroscopy in clinical gastroenterology and particularly in the study of colonic
mucosa in UC patients.
1.Introduction
Endoscopy has a recognized important role in diagnosis and
management in inﬂammatory bowel disease (IBD).
It can distinguish between Crohn’s disease (CD) and ul-
cerative colitis (UC), assess activity, extension of the disease,
and response to therapy, and it permits surveillance, espe-
cially in long-standing UC and extensive CD colitis patients,
for cancer and dysplasia.
Mucosal biopsy is a critical component of endoscopic
examination for patients with suspected IBD to diﬀerentiate
IBD from other causes of colitis such as bacterial infection,
ischemia, and NSAID use; biopsy specimens can help dif-
ferentiate CD from UC. Mucosal biopsy also helps to estab-
lish the extent of colon that is inﬂamed, which aids in deter-
miningprognosis,directingappropriatemedicalandsurgical
therapy and stratifying risk for dysplasia.
Moreover, histological ﬁndings have an important role in
predicting relapse, because patients with acute inﬂammatory
inﬁltrates seen on histological assessment are more likely to
experiencerelapsethanarethosewithoutinﬁltrates.Further-
more, some studies suggest that severity of inﬂammation is a
risk factor for colorectal neoplasia in UC [1].
Colonoscopy underestimates the extent of disease com-
pared with histology, and at present the extent of colitis
(pancolitis, left-sided colitis, or proctitis) should be based
on histologic examination rather than on endoscopy. Fur-
thermoretheassessmentofinﬂammationactivitybyconven-
tional colonoscopy is inaccurate in the prediction of acute
inﬂammation in some cases, especially for those seeming to
be in remission as evaluated by conventional colonoscopy.
Individuals with long-standing UC and extensive CD
colitis are at increased risk for development of dysplasia and
colorectal cancer (CRC) and should undergo colonoscopic
surveillance. Surveillance of patients with ulcerative colitis
consists of taking targeted and random biopsies. Biopsy
specimens of the colon in patients with documented pan-
colitis should be obtained in all 4 quadrants every 10cm
from the cecum to the rectum, to obtain a minimum of 322 Gastroenterology Research and Practice
biopsy samples. Biopsy specimens should be obtained from
strictures, mass lesions, and macroscopic abnormalities. The
presence of high-grade dysplasia or multifocal low-grade
dysplasia in ﬂat mucosa and dysplasia-associated lesional
mass (DALM) is an indication for colectomy.
Taking many biopsies is time consuming, carries a low
but non negligible risk of secondary hemorrhage, and has
only moderate sensitivity for neoplasia detection especially
when random biopsies are taken.
In recent years many eﬀorts have been done to improve
the diagnostic power of endoscopy, and technology has pro-
vided the endoscopist new advanced tools such as chro-
moendoscopy, high-resolution and magniﬁcation endosco-
py, narrow-band imaging and autoﬂuorescence.
These new technologies oﬀer enhanced endoscopic ima-
ges that can predict the histopathological diagnosis of the
examined mucosa and target the biopsy to suspected and
representative spot of the mucosa. Reported results have
shown that these procedures had a better relation with his-
tology than did conventional colonoscopy. However, some
impractical aspects of dye-based chromoendoscopy, such
as longer procedure times and diﬀerent dye stainings and
washing techniques, contributed to its limited application.
Although these factors do not aﬀect the “virtual” chromoen-
doscopy methods, such as narrow-band imaging (NBI) or
Fujinon intelligent color enhancement (FICE), an extensive
review by the ASGE on these methods shows modest and
variable accuracy [2].
Confocal laser endomicroscopy (CLE) is a newly intro-
duced technique which provides real-time high-magniﬁed
images of the gastrointestinal mucosa during endoscopic
examination. It oﬀers the chance to the endoscopist to have
in vivo visualization of the histology of the mucosal epi-
thelium with its cellular and subcellular structures. CLE
during endoscopy has shown high agreement with the real
histology of the tissue. The current potential indications for
CLE imaging are broad and include almost all the cases in
which endoscopic biopsy is needed [1, 3–5].
To date various studies have addressed the potential of
CLE in UC patients evidencing that this technique can have
an important role in assessing the extension and the activity
of disease and in targeting biopsies, reducing the number
of useless biopsies and improving the early detection of
dysplasia.
In this paper, we will focus on the role of CLE as applied
to UC patients with a particular emphasis on the potential of
CLE in in surveillance programs.
2. Confocal Systems/Methods
CLE can be performed currently with 2 devices: one inte-
grated into an endoscope (Pentax, Tokyo, Japan, herein ter-
med eCLE) and one as a stand-alone probe (herein termed
pCLE) capable of passage through the accessory channel of
most endoscopes (Cellvizio, Mauna Kea Technologies, Paris,
France).
The Pentax confocal endoscopes (Pentax EG-3870CIK
upper endoscope and EC3870CILK colonoscope) generate
simultaneously endoscopic and confocal images, so the
endoscope working channel is available to use and can
c a p t u r ei m a g e sa td i ﬀerent depth levels from 0 to 250µm.
The Cellvizio endomicroscopy system probe can be used
with any endoscope through the working channel and has
diﬀerent probes which enable diﬀerent scanning depth levels
(40–70µm, 70–130µm-55–65µm). Single video frames are
reconstructed by a special computer algorithm (mosaicing)
in an image with an enlarged ﬁeld of view. The video
mosaicing technique as applied is based on a hierarchical
framework algorithm that is able to recover a globally
consistent alignment of the input frames, to compensate
for motion-induced distortions. The resulting video mosaics
combine all moving images, cancel motion artifacts, and
reconstitute panoramas of the tissues.
There are no data, at present, comparing pCLE with
eCLE to demonstrate the superiority of any single system.
pCLE has several advantages and disadvantages compared
witheCLE.AdvantagesincludethegreaterversatilityofpCLE
probes, which can be used in conjunction with virtually any
endoscope (high-resolution endoscopes, NBI, cholangio-
scope, etc.), ad hoc usage (such as when a lesion is detected
with a normal endoscope), and acquisition at video frame
rateof12frames/s,allowinginvivoimagingofcapillaryﬂow.
Disadvantages include a slightly lower resolution (approxi-
mately 1µm compared with 0.7µm for eCLE) and smaller
ﬁeld of view (240–600µm).
Unequivocally, this technology is best used in conjunc-
tion with other “red-ﬂag” techniques because of its minute
scanning area and thus is only appropriate for classiﬁcation
of tissue at a site already detected by standard or optically
enhanced endoscopy. Ideally, the “red-ﬂag” techniques such
as chromoendoscopy, narrow-band imaging, or autoﬂuo-
rescence imaging should be used to screen the mucosa
for “areas of interest,” which can then be interrogated by
CEM for a “histological” diagnosis. The best combination
in UC surveillance is between chromoendoscopy and CLE
as chromoendoscopy is the gold standard to detect regions
of suspicion that can be examined by CLE to conﬁrm
intraepithelial neoplasia and guide immediate therapy.
A ﬂuorescent contrast agent is needed to achieve high-
contrast images using CLE. Potentially suitable agents in hu-
mansareﬂuorescein,acriﬂavine,tetracycline,orcresylviolet.
The most commonly used in studies have been ﬂuores-
cein and acriﬂavine. Topical acriﬂavine is highly speciﬁc
for labeling acidic constituents staining cellular nuclei of
superﬁcial layers of the mucosa and may allow better dif-
ferentiation between intraepithelial neoplasia and cancer of
the GI tract. However, because of the risk of mutagenesis
related to this agent, its use in humans has been reduced.
Sodium ﬂuorescein is the agent of choice as it is non-
mutagenic and relatively inexpensive and it has been safely
used for decades in ophthalmology.
It is highly safe with most common side eﬀects being
short-term yellowish skin discoloration and bright-yellow-
colored urine. Transient and minor nausea and vomiting
were reported during angiography. Serious side eﬀects, such
as anaphylaxis or cardiac or respiratory eﬀects, are extremely
rare, and to date, have not been recorded in CLE.Gastroenterology Research and Practice 3
Table 1: Classiﬁcation of crypt architecture by e-CLE assessment in
ulcerative colitis [6].
CLE crypt architecture Description
(A) normal Regular arrangement and size of crypts
(B) chronic inﬂammation Irregular arrangement of crypts,
enlarged spaces between crypts
(C) acute inﬂammation
Dilation of crypt openings, more
irregular arrangement of crypts, and
enlarged spaces between crypts as
compared to type B
(D) acute inﬂammation Crypt destruction and/or crypt abscess
Intravenous injection of 1.0–5.0mL of a 10% solution
enables visualization of individual cells with strong contrast
of the capillary network. Cell nuclei and mucin are not
stained by ﬂuorescein and therefore appear dark.
Fluorescein, after binding serum albumin and staining
the vascular space, diﬀuses in the extravascular space and
stains the epithelium and the stromal tissue allowing visu-
alization of enterocytes, cellular inﬁltrate, surface epithelial
cells, blood vessels, and red blood cells.
3. Confocal Images Evaluation/Classiﬁcation
Kiesslich et al. in 2004 were the ﬁrst who deﬁned criteria for
classiﬁcation of e-CLE patterns of normal, regenerative, and
neoplastic tissue based on evaluation of crypts and vascular
architecture, named the Mainz confocal endomicroscopy
criteria [7]. The Miami classiﬁcation system was developed
for p-CLE images, on the base of a consensus of p-CLE
users reached during a meeting held in Miami, Florida,
in February 2009 [8]. Due to the signiﬁcant technical
diﬀerences compared with e-CLE (smaller ﬁeld of view, ﬁxed
depth), p-CLE images are not comparable to e-CLE images.
Atpresentthereisnotaworldwideacceptedclassiﬁcation
of CLE images in UC, and this is certainly a limit of this
technique. This reﬂects the fact that this is a recently intro-
duced technology, and few centers have published studies
on this technique up to now. The most used classiﬁcations
are showed in Tables 1, 2,a n d3 a n da r eb a s e do nc r y p t
architecture assessment and microvascular assessment [6, 9,
10].
The most frequent alterations in crypt architecture are
represented by dilation of crypt openings, more irregular
arrangement of crypts, enlarged spaces between crypt, crypt
destruction and/or crypt fusion, and crypt abscess with
ﬂuorescein leaks into the crypt lumen (therefore making the
lumen brighter than the surrounding epithelium) (Figures 1
and 2). Microvascular alterations are mainly represented by
dilated, prominent branching vessels.
Dysplasia is characterized by “dark” cells, with mucin
depletion and goblet cell/crypt density attenuation; the
architectural pattern is irregular, as well as the epithelial
thickness,withvilliformstructuresand“dark”epithelialbor-
der. The blood vessels are dilated and irregularly branched,
with poor orientation to adjunct tissue and ﬂuorescein
extravasation (Figures 3 and 4).
Table 2: Microvascular architecture by e-CLE assessment in
ulcerative colitis [7].
Vessel architecture Description
Normal
Hexagonal, honeycomb appearance
that presents a network of
capillaries outlining the stroma
surrounding the luminal openings
of the crypts
Inﬂammation-regenerative
Preserved hexagonal, honeycomb
appearance with a slight increase in
the number of capillaries
Dysplastic
Dilated and distorted vessels with
increased leakage; irregular
architecture, with little or no
orientation to the adjoining tissue
Table 3: Assessmentof crypt architecture and vessel architecture by
p-CLE in ulcerative colitis [8].
Crypt architecture Crypt fusion and distortion
Bright epithelium
Vessel architecture Dilated, prominent branching vessels
4. ClinicalApplicationandReview of
the Literature
CLE has the potential to have an important role in man-
agement of IBD patients. It cannot distinguish between CD
and UC as it cannot be used to make a diagnosis, but it can
assess the grading of colitis and detect microscopic colitis in
endoscopically silent segments. Moreover, CLE can be used
in surveillance programs especially in high-risk patients.
AtpresentmostoftheliteratureisabouttheuseofCLEin
UC patients, to monitor disease activity and for surveillance.
Watanabe et al. [9]a n dL ie ta l .[ 6] reported on real-time
inﬂammation activity assessment by CLE. The inﬂamma-
tion activity assessment includes crypt architecture, cellular
inﬁltration, and vessel architecture. These studies evidenced
that images taken with the CLE provided information that
was equivalent to conventional histology, diﬀerentiating
between active and nonactive CUC patients during ongoing
endoscopy.
CLE may be useful particularly in the surveillance of
patients with UC, where suspicious lesions can be evaluated
in vivo, reducing the need forrandom biopsies by combining
CLE with chromoendoscopy.
Several randomized studies have shown that targeting
biopsies with chromoendoscopy signiﬁcantly increases dys-
plasia detection rates in patients with long-standing ulcer-
ative colitis [11, 12]. Chromoendoscopy was demonstrated,
in fact, to have a higher sensitivity than conventional white
lightcolonoscopyinthedetectionofdysplasiainUCpatients
while it has a low speciﬁcity. CLE has a high speciﬁcity so
it would be ideal to join the two techniques in cancer and
dysplasia surveillance.
In a randomized study on 161 patients with long-term
UC, pan-chromoendoscopy has been used to detect ﬂat or
suspected lesion and targeted CLE of the detected lesions4 Gastroenterology Research and Practice
Figure 1: p-CLE ﬂuorescein sodium 10% imaging of the normal colon showing hexagonal, honeycomb appearance with a regular-ordered
network of capillaries demarcating the luminal crypt oriﬁce. Surface crypt architecture was classically represented by ordered and regular
crypt oriﬁces covered by a homogeneous epithelial layer with visible “black-hole” goblet cells within the subcellular matrix.
(a) (b)
Figure 2: p-CLE ﬂuorescein sodium 10% imaging examples of crypt types of patients in active ulcerative colitis. (a) crypt fusion and
distortion; (b) dilation of crypt openings, with ﬂuorescein leaks into the crypt lumen therefore making the lumen brighter than the
surrounding epithelium.
Figure 3: p-CLE ﬂuorescein sodium 10% imaging of vessel architecture in ulcerative colitis: preserved hexagonal, honeycomb appearance
with slightly dilated capillaries.Gastroenterology Research and Practice 5
(a) (b)
Figure 4: p-CLE ﬂuorescein sodium 10% imaging of dysplastic epithelium in ulcerative colitis. (a) the architectural pattern of crypt is
irregular, with epithelial thickness, villiform structures, and “dark” epithelial border. (b) the vessel architecture shows tortuous and dilated
capillaries.
to diﬀerentiate between neoplastic and nonneoplastic tissue.
By using this diagnostic approach, Kiesslich et al. detected
4.75 times more dysplastic lesions than with conventional
endoscopy. There was a reduction in the number of biopsy
specimens by half. In addition, CLE was able to predict
neoplastic changes with an accuracy of 97.8% [13].
Apilotstudyon22patientsofvandenBroekinvestigated
the feasibility and diagnostic accuracy of CLE in conjunction
with NBI high deﬁnition endoscopy in surveillance of
patients with long-standing UC [10].
Theyreportedadiagnosticaccuracyof81%,withamod-
erateinterobserveragreement,reﬂectingtheirminimalexpe-
rience with this technique, that certainly needs a learning
curve to obtain the best results. They also reported an
additional time to colonoscopy of 30–40 minutes to capture
imagesthatwereevaluatedinasecondtime,andvideoimage
quality was than rated as good–excellent only in 69%. For
sure, the time needed to perform CLE and to use it to have
real-time evaluation of colonic mucosa and taking on-table
decisionisalimittothegeneralapplicationofCLEinclinical
practice.
Hurlstone et al. [2] assessed the clinical applicability and
predictive power of the CLE for the in vivo diﬀerentiation of
ALM and DALM in CUC. The in vivo diagnosis of DALM
and ALM using CLE matched the histological evaluation,
with a kappa coeﬃcient of 0.91 and an accuracy of 97%. The
study evidenced that ALM and DALM can be diﬀerentiated
with a high overall accuracy, enabling the safe selection of
patients suitableforendoluminal resection versusimmediate
referral for surgery. In a recent case report of our group,
pCLE has been used to characterize a DALM in a long-
standing UC with high correlation between CLE and stan-
dard histopathological examination [14].
5. Conclusions
CLE is a new technique that promises to be an important
imaging tool in the management of patients with UC; it can
be used to assess and score IBD activity and to monitor
response to therapy and it has the potential to allow the
developing of new activity markers, without the need for
histological conﬁrmation.
It can avoid unuseful biopsy, precisely target biopsy on
suspected area, and allow on-table management decision in
surveillance.
This technology is best used in conjunction with other
“red-ﬂag” techniques and thus can be used for classiﬁcation
of tissue at a site already detected by standard or enhanced
endoscopy. Ideally a red-ﬂag technique such as chromoen-
doscopy should be used to screen the mucosa for areas of
interest, to examine with CLE for a histological diagnosis.
The joining of the two techniques could lead to a higher
diagnosticaccuracyinsurveillanceendoscopyinUCpatients
and to the detection of neoplasia at an earlier and curative
stage.
There are some limitations to the application in general
practice: the need for a learning curve, the cost of the equip-
ment the need for an extra time to enhanced colonoscopy,
andthepromisingresultsintheliteraturebeingderivedfrom
still a few experienced centers. New multicenter studies are
needed to assess the cost eﬀectiveness of this technique for
surveillance endoscopy in UC.
CLE is a new technology, with the potential, with ap-
propriatetrainingandcarefulpatientselection,tobecomean
important imaging modality in the complex clinical scenario
of UC cancer and dysplasia surveillance.
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